Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells

Previous vaccination studies in patients with castration-resistant prostate cancer (CRPC) showed improved survival without prolongation of progression-free survival (PFS). This might be explained by enhanced efficacy of subsequent therapies because of heightened immune status. We therefore evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dodewaard-de Jong, Joyce M., Santegoets, Saskia JAM, van de Ven, Peter M., Versluis, Jurjen, Verheul, Henk M. W., de Gruijl, Tanja D., Gerritsen, Winald R., van den Eertwegh, Alfons J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839338/
https://www.ncbi.nlm.nih.gov/pubmed/27141390
http://dx.doi.org/10.1080/2162402X.2015.1105431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839338/
https://www.ncbi.nlm.nih.gov/pubmed/27141390
http://dx.doi.org/10.1080/2162402X.2015.1105431

Ejemplares similares